Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

Methods for treating cognitive/attention deficit disorders using tetrahydroindolone analogues and derivatives

US Patent 8734818 · Granted May 27, 2014

Estimated economic value: $4,659,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of organophosphate exposure with triptans2020
Treatment of organophosphate exposure with triptans2020
Emesis treatment2020
Treatment of organophosphate exposure with ocinaplon2019
Use of cyproheptadine to treat organophosphate exposure2019
Use of cyproheptadine to treat organophosphate exposure2019
Emesis treatment2019
Emesis treatment2018
Assay for determination of compounds having anti-emetic activity2014
Assay for determination of compounds having anti-emetic activity2014
Tetrahydroindolone derivatives for treatment of neurological conditions2013
Tetrahydroindolone derivatives for treatment of neurological conditions2013